Wells Fargo & Company Paratek Pharmaceuticals, Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 15, 2023	SELL	$1.52 - $2.8 $383 - $705	-252 Reduced 1.14%	21,782 $48,000
Q1 2023 May 12, 2023	SELL	$1.37 - $2.54 $2,768 - $5,133	-2,021 Reduced 8.4%	22,034 $55,000
Q4 2022 Feb 13, 2023	BUY	$1.67 - $2.51 $23,673 - $35,581	14,176 Added 143.5%	24,055 $44,000
Q3 2022 Nov 14, 2022	SELL	$1.96 - $2.93 $50 - $76	-26 Reduced 0.26%	9,879 $26,000
Q2 2022 Aug 12, 2022	SELL	$1.73 - $3.09 $148,259 - $264,809	-85,699 Reduced 89.64%	9,905 $19,000
Q1 2022 May 16, 2022	SELL	$2.94 - $4.77 $401,598 - $651,572	-136,598 Reduced 58.83%	95,604 $284,000
Q4 2021 Feb 14, 2022	SELL	$4.07 - $5.3 $23,549 - $30,665	-5,786 Reduced 2.43%	232,202 $1.04 Million
Q3 2021 Nov 15, 2021	SELL	$4.7 - $7.24 $166,079 - $255,832	-35,336 Reduced 12.93%	237,988 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$6.81 - $10.93 $287,075 - $460,754	42,155 Added 18.24%	273,324 $1.86 Million
Q1 2021 May 13, 2021	BUY	$6.14 - $8.31 $607,657 - $822,415	98,967 Added 74.86%	231,169 $1.63 Million
Q4 2020 Feb 09, 2021	BUY	$4.58 - $7.14 $97,389 - $151,824	21,264 Added 19.17%	132,202 $828,000
Q3 2020 Nov 05, 2020	SELL	$4.19 - $6.69 $9,389 - $14,992	-2,241 Reduced 1.98%	110,938 $600,000
Q2 2020 Aug 13, 2020	BUY	$2.97 - $5.22 $204,520 - $359,459	68,862 Added 155.39%	113,179 $591,000
Q1 2020 May 14, 2020	BUY	$2.67 - $4.97 $118,326 - $220,255	44,317 New	44,317 $140,000

1.54M

Ticker PRTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,862,500
Description
Paratek Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of life-saving therapies for life-threatening diseases or other public health threats for civilian, government, and military use. Its lead product candidates include NUZYRA, a once-daily oral and intravenous broad-spectru...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.